Drug Delivery across Biological Barriers, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 226
Special Issue Editors
Interests: biopolymers; pharmaceutics; bioconjugation; bioanalysis; ligand–receptor interactions; peptides; drug delivery
Special Issues, Collections and Topics in MDPI journals
2. Institute of Chemistry, Saint-Petersburg State University, Universitetsky pr. 26, 198504 St. Petersburg, Russia
Interests: amphiphilic polymers; self-assembling; nanoparticles; biodegradation; drug delivery systems; proteins; peptides; DNA/RNA
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Assuring the efficient transport of therapeutics in the body is a crucial problem that should be taken into consideration during the construction of advanced drug delivery nanosystems. Recent advances in the development of biomaterials, including their nanoparticulated forms, have rendered a significant improvement of the currently proposed drug delivery strategies. In addition to the increased bioavailability of pharmaceutical agents as a result of protecting them from degradation, targeting them directly to diseased sites, and controlling their circulation time and release rate, the problem of penetration across tissues and/or entry within cells seems to be important and needs to be solved. The design of strategies to control the transport of therapeutic compounds through such physiological barriers as mucosal, endothelial, blood–brain, cellular membrane and numerous other barriers has become an imperative and a challenging need to provide better therapy efficacy.
This Special Issue will provide readers with an overview of the current advances in this field regarding delivery systems that facilitate the transport of drug-containing nanosystems at the tissue, cell, and subcellular levels.
Prof. Dr. Tatiana B. Tennikova
Dr. Evgenia G. Korzhikova-Vlakh
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- nanosystems
- biological barriers
- drug transport across barriers
Related Special Issue
- Drug Delivery across Biological Barriers in Pharmaceutics (10 articles)
